First Time Loading...

Adaptimmune Therapeutics PLC
NASDAQ:ADAP

Watchlist Manager
Adaptimmune Therapeutics PLC Logo
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Watchlist
Price: 1.04 USD -0.95% Market Closed
Updated: May 29, 2024

Adaptimmune Therapeutics PLC
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Adaptimmune Therapeutics PLC
Short-Term Investments Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Short-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Short-Term Investments
$3m
CAGR 3-Years
-78%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Short-Term Investments
$128.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Adaptimmune Therapeutics PLC's Short-Term Investments?
Short-Term Investments
3m USD

Based on the financial report for Mar 31, 2024, Adaptimmune Therapeutics PLC's Short-Term Investments amounts to 3m USD.

What is Adaptimmune Therapeutics PLC's Short-Term Investments growth rate?
Short-Term Investments CAGR 5Y
-52%

Over the last year, the Short-Term Investments growth was -93%. The average annual Short-Term Investments growth rates for Adaptimmune Therapeutics PLC have been -78% over the past three years , -52% over the past five years .